|
1
|
Shike M, Winawer SJ, Greenwald PH, Bloch
A, Hill MJ and Swaroop SV: Primary prevention of colorectal cancer.
The WHO Collaborating Centre for the Prevention of Colorectal
Cancer Bull World Health Organ. 68:377–385. 1990.
|
|
2
|
Sasaki H, Miura K, Horii A, et al:
Orthotopic implantation mouse model and cDNA microarray analysis
indicates several genes potentially involved in lymph node
metastasis of colorectal cancer. Cancer Sci. 99:711–719. 2008.
View Article : Google Scholar
|
|
3
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu WK, Law PT, Lee CW, et al: MicroRNA in
colorectal cancer: from benchtop to bedside. Carcinogenesis.
32:247–253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lima RT, Busacca S, Almeida GM, Gaudino G,
Fennell DA and Vasconcelos MH: MicroRNA regulation of core
apoptosis pathways in cancer. Eur J Cancer. 47:163–174. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wilmott JS, Zhang XD, Hersey P and Scolyer
RA: The emerging important role of microRNAs in the pathogenesis,
diagnosis and treatment of human cancers. Pathology. 43:657–671.
2011.PubMed/NCBI
|
|
9
|
Luo X, Burwinkel B, Tao S and Brenner H:
MicroRNA signatures: novel biomarker for colorectal cancer? Cancer
Epidemiol Biomarkers Prev. 20:1272–1286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dhayat S, Mardin WA, Mees ST and Haier J:
Epigenetic markers for chemosensitivity and chemoresistance in
pancreatic cancer - a review. Int J Cancer. 129:1031–1041. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim TY, Jong HS, Jung Y, Kim TY, Kang GH
and Bang YJ: DNA hypermethylation in gastric cancer. Aliment
Pharmacol Ther. 20(Suppl 1): S131–S142. 2004. View Article : Google Scholar
|
|
12
|
Oue N, Kuraoka K, Kuniyasu H, et al: DNA
methylation status of hMLH1, p16(INK4a), and CDH1 is not associated
with mRNA expression levels of DNA methyltransferase and DNA
demethylase in gastric carcinomas. Oncol Rep. 8:1085–1089.
2001.PubMed/NCBI
|
|
13
|
Momparler RL: Epigenetic therapy of cancer
with 5-aza-2′-deoxycytidine (decitabine). Semin Oncol. 32:443–451.
2005.
|
|
14
|
Kozaki K, Imoto I, Mogi S, Omura K and
Inazawa J: Exploration of tumor-suppressive microRNAs silenced by
DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lewis A, Mitsuya K, Umlauf D, et al:
Imprinting on distal chromosome 7 in the placenta involves
repressive histone methylation independent of DNA methylation. Nat
Genet. 36:1291–1295. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Balaguer F, Link A, Lozano JJ, et al:
Epigenetic silencing of miR-137 is an early event in colorectal
carcinogenesis. Cancer Res. 70:6609–6618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bandres E, Agirre X, Bitarte N, et al:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toyota M, Suzuki H, Sasaki Y, et al:
Epigenetic silencing of microRNA-34b/c and B-cell translocation
gene 4 is associated with CpG island methylation in colorectal
cancer. Cancer Res. 68:4123–4132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lujambio A, Ropero S, Ballestar E, et al:
Genetic unmasking of an epigenetically silenced microRNA in human
cancer cells. Cancer Res. 67:1424–1429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiyomaru T, Enokida H, Kawakami K, et al:
Functional role of LASP1 in cell viability and its regulation by
microRNAs in bladder cancer. Urol Oncol. Sep 14–2010.(Epub ahead of
print).
|
|
21
|
Kojima S, Chiyomaru T, Kawakami K, et al:
Tumour suppressors miR-1 and miR-133a target the oncogenic function
of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J
Cancer. 106:405–413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nohata N, Hanazawa T, Kikkawa N, et al:
Identification of novel molecular targets regulated by tumor
suppressive miR-1/miR-133a in maxillary sinus squamous cell
carcinoma. Int J Oncol. 39:1099–1107. 2011.PubMed/NCBI
|
|
23
|
Rao PK, Missiaglia E, Shields L, et al:
Distinct roles for miR-1 and miR-133a in the proliferation and
differentiation of rhabdomyosarcoma cells. FASEB J. 24:3427–3437.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshino H, Chiyomaru T, Enokida H, et al:
The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Datta J, Kutay H, Nasser MW, et al:
Methylation mediated silencing of MicroRNA-1 gene and its role in
hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Ye Y, Shen D, et al:
Identification of transgelin-2 as a biomarker of colorectal cancer
by laser capture microdissection and quantitative proteome
analysis. Cancer Sci. 101:523–529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao L, Wang H, Liu C, et al: Promotion of
colorectal cancer growth and metastasis by the LIM and SH3 domain
protein 1. Gut. 59:1226–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kuwabara Y, Ono K, Horie T, et al:
Increased microRNA-1 and microRNA-133a levels in serum of patients
with cardiovascular disease indicate myocardial damage. Circ
Cardiovasc Genet. 4:446–454. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He B, Xiao J, Ren AJ, et al: Role of miR-1
and miR-133a in myocardial ischemic postconditioning. J Biomed Sci.
18:222011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bostjancic E, Zidar N, Stajer D and Glavac
D: MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated
in human myocardial infarction. Cardiology. 115:163–169. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hudson RS, Yi M, Esposito D, et al:
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in
human prostate cancer. Nucleic Acids Res. 40:3689–3703. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Migliore C, Martin V, Leoni VP, et al:
MiR-1 downregulation cooperates with MACC1 in promoting MET
overexpression in human colon cancer. Clin Cancer Res. 18:737–747.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nasser MW, Datta J, Nuovo G, et al:
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression
of tumorigenic property of lung cancer cells and their
sensitization to doxorubicin-induced apoptosis by miR-1. J Biol
Chem. 283:33394–33405. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sarver AL, French AJ, Borralho PM, et al:
Human colon cancer profiles show differential microRNA expression
depending on mismatch repair status and are characteristic of
undifferentiated proliferative states. BMC Cancer. 9:4012009.
View Article : Google Scholar
|
|
36
|
Yan D, da Dong XE, Chen X, et al:
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma
development. J Biol Chem. 284:29596–29604. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yoshino H, Enokida H, Chiyomaru T, et al:
Tumor suppressive microRNA-1 mediated novel apoptosis pathways
through direct inhibition of splicing factor serine/arginine-rich 9
(SRSF9/SRp30c) in bladder cancer. Biochem Biophys Res Commun.
417:588–593. 2012. View Article : Google Scholar
|
|
38
|
Kano M, Seki N, Kikkawa N, et al: miR-145,
miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in
esophageal squamous cell carcinoma. Int J Cancer. 127:2804–2814.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma Y, Zhang P, Yang J, Liu Z, Yang Z and
Qin H: Candidate microRNA biomarkers in human colorectal cancer:
Systematic review profiling studies and experimental validation.
Int J Cancer. 130:2077–2087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Moriya Y, Nohata N, Kinoshita T, et al:
Tumor suppressive microRNA-133a regulates novel molecular networks
in lung squamous cell carcinoma. J Hum Genet. 57:38–45. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nohata N, Hanazawa T, Kikkawa N, et al:
Caveolin-1 mediates tumor cell migration and invasion and its
regulation by miR-133a in head and neck squamous cell carcinoma.
Int J Oncol. 38:209–217. 2011.PubMed/NCBI
|
|
42
|
Wu ZS, Wang CQ, Xiang R, et al: Loss of
miR-133a expression associated with poor survival of breast cancer
and restoration of miR-133a expression inhibited breast cancer cell
growth and invasion. BMC Cancer. 12:512012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rho JH, Roehrl MH and Wang JY: Tissue
proteomics reveals differential and compartment-specific expression
of the homologs transgelin and transgelin-2 in lung adenocarcinoma
and its stroma. J Proteome Res. 8:5610–5618. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Leung WK, Ching AK, Chan AW, et al: A
novel interplay between oncogenic PFTK1 protein kinase and tumor
suppressor TAGLN2 in the control of liver cancer cell motility.
Oncogene. 30:4464–4475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Suzuki H, Takatsuka S, Akashi H, et al:
Genome-wide profiling of chromatin signatures reveals epigenetic
regulation of MicroRNA genes in colorectal cancer. Cancer Res.
71:5646–5658. 2011. View Article : Google Scholar
|
